Your browser doesn't support javascript.
loading
4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer.
Sakellariou-Thompson, Donastas; Forget, Marie-Andrée; Creasy, Caitlin; Bernard, Vincent; Zhao, Li; Kim, Young Uk; Hurd, Mark W; Uraoka, Naohiro; Parra, Edwin Roger; Kang, Ya'an; Bristow, Christopher A; Rodriguez-Canales, Jaime; Fleming, Jason B; Varadhachary, Gauri; Javle, Milind; Overman, Michael J; Alvarez, Hector A; Heffernan, Timothy P; Zhang, Jianhua; Hwu, Patrick; Maitra, Anirban; Haymaker, Cara; Bernatchez, Chantale.
Afiliação
  • Sakellariou-Thompson D; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Forget MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Creasy C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bernard V; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhao L; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kim YU; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hurd MW; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Uraoka N; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kang Y; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bristow CA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rodriguez-Canales J; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fleming JB; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Varadhachary G; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Javle M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Alvarez HA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heffernan TP; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hwu P; Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Maitra A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Haymaker C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bernatchez C; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 23(23): 7263-7275, 2017 Dec 01.
Article em En | MEDLINE | ID: mdl-28947567
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Imunoterapia Adotiva / Linfócitos do Interstício Tumoral / Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Imunoterapia Adotiva / Linfócitos do Interstício Tumoral / Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article